Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05266105
Title A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries AUS

No variant requirements are available.